hBiP (human binding immunoglobulin protein) is one of the most important endoplasmic reticulum (ER) chaperone proteins, which plays a key role in protein folding, export into the ER, assembly, signal transduction and calcium ion homeostasis\(^{[1]}\). When ER stress occurs during cancer and neurodegenerative illnesses, hBiP appears to be involved in disease progression, tissue damage and autoimmune inflammation\(^{[2][3]}\). Therefore, hBiP could be a potential biomarker for detecting and monitoring these diseases. Monoclonal antibodies are great biotechnological tools for investigation of various proteins and their roles\(^{[4]}\). Antibodies could be used in the development of immunoassays for the quantification of their targets. In this study, we aim to develop and optimize the assay for hBiP detection and concentration determination while using monoclonal antibodies in the sandwich ELISA method. Test conditions were optimized, such as type of plate, immobilization and blocking solutions and monoclonal antibodies pair. It is important to develop a reliable test for quantification of hBiP to detect and monitor previously mentioned diseases, hence the accuracy of the test was evaluated. When developed, such a test can contribute to improve the understanding of the role of hBiP in disease pathogenesis and facilitate the development of personalized medicine approaches.
DEVELOPMENT AND OPTIMIZATION OF A MONOCLONAL ANTIBODY-BASED SYSTEM FOR QUANTIFICATION OF hBiP
Gabija Klimavičiūtė1, Evaldas Čiplys2, Rimantas Slibinskas2, Aurelija Žvirblienė1, Martynas Simanavičius1
1 Vilnius University, Life Sciences Center, Institute of Biotechnology, Department of Immunology
2 Vilnius University, Life Sciences Center, Institute of Biotechnology, Department of Eukaryote Gene Engineering
[1] Ni, M., Zhang, Y., Lee, A. S. Beyond the Endoplasmic Reticulum: Atypical GRP78 in Cell Viability, Signalling and Therapeutic Targeting. Biochem J 2011, 434 (2), 181-188.
[2] Zhang, L.-H., Zhang, X. Roles of GRP78 in Physiology and Cancer. J Cell Biochem 2010, 110 (6), 1299-1305.
[3] Gorbatyuk, M. S., Gorbatyuk, O. S. The Molecular Chaperone GRP78-BiP as a Therapeutic Target for Neurodegenerative Disorders: A Mini Review. J Genet Syndr Gene Ther 2013, 4 (2), 128.
[4] Zahavi, D. Weiner, L. Monoclonal Antibodies in Cancer Therapy. Antibodies (Basel) 2020, 9 (3), 34.